News archive for Department of Clinical Medicine
Our multidisciplinary research group aims to investigate pediatric hip disorders through multiple approaches. That is why our research includes genetic epidemiology with the purpose of unravelling why some individuals are prone to getting these disorders. Recently, we published a large genome-wide association study (GWAS) on hip dysplasia, implicating a collagen gene in the development of hip... Read more
Developmental dysplasia of the hip (DDH) is a congenital disorder in which the etiology, risk factors and life course are not fully understood.
We give you a springtime update on the activities of NutriNOR – Norway’s national research school in nutrition.
Karen Rosnes Gissum defended June 28, 2024 her PhD thesis "Unveiling the Complexities: Patients’ and Healthcare Providers’ Perspectives on Understanding and Managing Ovarian Cancer" at the University of Bergen. This is a unique CCBIO doctorate work focusing on the patient and healthcare worker perspective and not the actual research. Nevertheless, objective measures like biomarkers were seen as... Read more
In a new doctoral work at CCBIO, by Christiane Helgestad Gjerde, the group has established a 3D in vitro model of high-grade serous ovarian carcinoma to assess the efficacy of traditional chemotherapy and novel cell-based immunotherapies. This model makes out a more realistic mini tumor, making it possible to test which therapy that works on this type of cancer. The knowledge provided from this... Read more
From May 28th to 30th, EBV-MS Partner Paola Zaratin, along with the Italian MS Society, hosted the Annual Scientific Congress 2024. Notable attendees included EBV-MS Project Coordinator Kjell-Morten Myhr, Deputy Project Coordinator Øivind Torkildsen, and project partner Marco Salvetti from Sapienza University of Rome, all invited by the Italian MS Society, ensuring significant representation from... Read more
On Wednesday, June 5th, 2024, a productive introduction between the consortium and the Scientific Advisory Board (SAB) was conducted during a recent gathering. The meeting marked a positive commencement of the collaboration between the SAB and the members of the EBV-MS project.
On Tuesday, January 23rd, and Wednesday, January 24th, 2024, the EBV-MS project successfully held its inaugural kick-off meeting. This meeting provided an opportunity for the project team to get acquainted, share insights, and set goals. The program was structured to cover various aspects of the project, including the introduction of partners, presentation of work packages, and discussions on... Read more
The doctoral work of Ole Vidhammer Bjørnstad, which includes three coming scientific papers, has shed light on the occurrence of neural precursor cells in breast cancer, and the interactions between neural precursor cells and breast cancer cells.
Prof. Ix is Professor and Division Chief in the Department of Medicine, Division of Nephrology-Hypertension (UC San Diego) & Prof. Stein Ivar Hallan (Specialist in internal medicine, kidney diseases and clinical chemistry) were both visting the Renal Research Group at University of Bergen to discuss future collaboration between the three research groups (June 10th 2024).
The Norwegian Academy of Science and Letters June 12th announced the 2024 Kavli Prize Laureates in the fields of astrophysics, nanoscience and neuroscience. Among these are Robert S. Langer (USA), sharing the 2024 Kavli Prize in Nanoscience with Armand Paul Alivisatos (USA) and Chad A. Mirkin (USA).
Although patient involvement in research was not part of the program at the 12th CCBIO Annual Symposium, it is a topic CCBIO will give more attention to. We had a chat with a user representative who participated at the symposium, and who is also contributing in one of our research projects.
The 12th CCBIO Annual Symposium has recently taken place, with a program showcasing current cancer biomarker research. This was the final symposium in CCBIO’s 10-year period funded by the Research Council of Norway as a Centre of Excellence (CoE), however not the last. CCBIO will continue its core activities, maintaining what has become a strong cancer research network.
Although CCBIO this summer completes its 10-year appointment as Center of Excellence by the Research Council of Norway, the center will continue its activities, and so do all the research groups and collaborations that have been established through these years. It has been a privilege for the CCBIO leadership to follow these groups from the very beginning and watch them grow and now continue to... Read more
The 12th CCBIO Annual Symposium took place May 14-15, 2024, at Solstrand outside of Bergen in excellent weather, facilitating a radiant frame for networking and meetings in the sunshine during the breaks. The program showcased current cancer biomarker research as well as taking a step back considering global perspectives on cancer.
Did you know that UiB coordinates a European initiative to target the cause of MS?
During 2017-2019, systematic differences in high efficacy MS-treatment strategies were preferred in Oslo (cladribine) and Bergen (rituximab). Comparisons of long-term (median 4.5 years) effects from these different treatments showed a 2.7 higher risk for new MRI disease activity after four years in the cladribine group (n=132) compared to rituximab group (n=168).
Pages
- July 2024 (3)
- June 2024 (11)
- May 2024 (3)
- December 2023 (6)
- October 2023 (4)
- September 2023 (1)
- August 2023 (1)
- June 2023 (2)
- May 2023 (4)
- April 2023 (2)
- February 2023 (1)
- January 2023 (1)
- December 2022 (4)
- November 2022 (4)
- October 2022 (3)
- September 2022 (1)
- June 2022 (1)
- May 2022 (1)
- April 2022 (2)
- March 2022 (2)
- November 2021 (3)
- October 2021 (3)
- September 2021 (1)
- June 2021 (2)
- May 2021 (1)
- March 2021 (1)
- December 2020 (3)
- October 2020 (2)
- September 2020 (1)
- August 2020 (1)
- June 2020 (3)
- April 2020 (2)
- March 2020 (1)
- February 2020 (2)
- January 2020 (4)
- December 2019 (2)
- November 2019 (2)
- October 2019 (1)
- September 2019 (4)
- June 2019 (2)
- May 2019 (2)
- April 2019 (1)
- March 2019 (3)
- February 2019 (1)
- January 2019 (2)
- December 2018 (5)
- November 2018 (4)
- October 2018 (8)
- September 2018 (4)
- August 2018 (2)
- June 2018 (3)
- May 2018 (2)
- April 2018 (1)
- March 2018 (2)
- February 2018 (1)
- December 2017 (3)
- November 2017 (4)
- October 2017 (1)
- September 2017 (2)
- August 2017 (1)
- June 2017 (5)
- May 2017 (1)
- April 2017 (2)
- March 2017 (2)
- February 2017 (1)
- January 2017 (2)
- December 2016 (3)
- November 2016 (3)
- October 2016 (3)
- September 2016 (5)
- June 2016 (2)
- May 2016 (1)
- April 2016 (2)
- March 2016 (1)
- February 2016 (1)
- January 2016 (1)
- December 2015 (1)
- November 2015 (2)
- October 2015 (5)
- September 2015 (5)
- August 2015 (3)
- July 2015 (3)
- June 2015 (6)
- May 2015 (3)
- April 2015 (2)
- March 2015 (3)
- February 2015 (6)
- January 2015 (9)
- December 2014 (3)
- November 2014 (1)
- October 2014 (7)
- September 2014 (4)
- August 2014 (2)
- June 2014 (3)
- April 2014 (1)
- February 2014 (1)
- January 2014 (1)
- December 2013 (2)
- November 2013 (1)
- October 2013 (1)
- September 2013 (1)
- May 2013 (1)
- March 2012 (2)
- February 2012 (3)
- November 2010 (1)
- October 2010 (1)
- February 2010 (1)
- January 2010 (1)